Sign in
4

Changes in Ownership

ENANTA PHARMACEUTICALS INC Filed Acc 0001177648-18-000036

Sr. VP & General Counsel acquired 1,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Gardiner Nathaniel S. · Sr. VP & General Counsel

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2018-10-01 Exercise or conversion : show line 1 in the form +1,500 $34.70 $52,050 13,827 D

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2018-10-01 Exercise or conversion : show line 2 in the form Stock Option (right to buy) −1,500 $34.70 2024-05-09 1,500 76,700 D
Loading xslF345X03/edgar.xml…